Literature DB >> 33746400

Serum levels of CC chemokine ligands in cutaneous leishmaniasis patients.

Gholamhossein Hassanshahi1,2, Seyed Ebrahim Alavi3, Hossein Khorramdelazad1, Zahra Ahmadi1, Ali Fattahi Bafghi4, Seyed Hossein Abdollahi1,5, Hasan Ebrahimi Shahmabadi5.   

Abstract

The crucial functions of chemokine/receptors in numerous parasitic infections, including leishmaniasis, are well documented. This study aimed to assess the serum levels of CC ligand (CCL) 2, CCL5, and CCL11 in cutaneous leishmaniasis (CL) patients. 64 patients, suffering from CL and 100 healthy people were selected, and their blood serum concentrations of CCL2, CCL5, and CCL11 were measured using enzyme-linked immunosorbent assay. The results demonstrated that while the mean serum levels of CCL5 and CCL11 increased significantly in CL patients, the mean serum levels of CCL2 decreased, compared to the control group. Despite the sufficient production of CCL5 and CCL11 in CL patients, they suffered from CCL2 deficiency, as the defense mechanism against parasitic infection. These findings suggest a mechanism that might partially explain the patients' susceptibility to persistent infection and their inability to clear the parasites. © Indian Society for Parasitology 2020.

Entities:  

Keywords:  CC ligand; Chemokines; Leishmaniasis; Parasitic infection

Year:  2020        PMID: 33746400      PMCID: PMC7921228          DOI: 10.1007/s12639-020-01290-w

Source DB:  PubMed          Journal:  J Parasit Dis        ISSN: 0971-7196


  29 in total

Review 1.  Chemokines in host-parasite interactions in leishmaniasis.

Authors:  Maria Jania Teixeira; Clarissa Romero Teixeira; Bruno Bezerril Andrade; Manoel Barral-Netto; Aldina Barral
Journal:  Trends Parasitol       Date:  2005-11-23

2.  Expression of CXC chemokine IP-10/Mob-1 by primary hepatocytes following heat shock.

Authors:  Gholamhossein Hassanshahi; Sanjai S Patel; Abdollah A Jafarzadeh; Alan J Dickson
Journal:  Saudi Med J       Date:  2007-04       Impact factor: 1.484

Review 3.  A beginner's guide to chemokines.

Authors:  Victoria Vinader; Kamyar Afarinkia
Journal:  Future Med Chem       Date:  2012-05       Impact factor: 3.808

4.  Chronicity of dermal leishmaniasis caused by Leishmania panamensis is associated with parasite-mediated induction of chemokine gene expression.

Authors:  Adriana Navas; Deninson Alejandro Vargas; Marina Freudzon; Diane McMahon-Pratt; Nancy Gore Saravia; María Adelaida Gómez
Journal:  Infect Immun       Date:  2014-04-21       Impact factor: 3.441

5.  The roles of complement receptor 3 and Fcγ receptors during Leishmania phagosome maturation.

Authors:  Rachel Polando; Upasna Gaur Dixit; Cristina R Carter; Blake Jones; James P Whitcomb; Wibke Ballhorn; Melissa Harintho; Christopher L Jerde; Mary E Wilson; Mary Ann McDowell
Journal:  J Leukoc Biol       Date:  2013-03-29       Impact factor: 4.962

Review 6.  Role of chemokines in regulation of immunity against leishmaniasis.

Authors:  Steve Oghumu; Claudio M Lezama-Dávila; Angelica P Isaac-Márquez; Abhay R Satoskar
Journal:  Exp Parasitol       Date:  2010-03-03       Impact factor: 2.011

Review 7.  Visceral leishmaniasis: current status of control, diagnosis, and treatment, and a proposed research and development agenda.

Authors:  Philippe J Guerin; Piero Olliaro; Shyam Sundar; Marleen Boelaert; Simon L Croft; Philippe Desjeux; Monique K Wasunna; Anthony D M Bryceson
Journal:  Lancet Infect Dis       Date:  2002-08       Impact factor: 25.071

8.  Modeling spatial distribution of Rhombomys opimus as the main reservoir host of zoonotic cutaneous leishmaniasis in northeastern Iran.

Authors:  A Sofizadeh; A A Hanafi-Bojd; H R Shoraka
Journal:  J Vector Borne Dis       Date:  2018 Oct-Dec       Impact factor: 1.688

Review 9.  More Than Just Attractive: How CCL2 Influences Myeloid Cell Behavior Beyond Chemotaxis.

Authors:  Martha Gschwandtner; Rupert Derler; Kim S Midwood
Journal:  Front Immunol       Date:  2019-12-13       Impact factor: 7.561

Review 10.  A guide to chemokines and their receptors.

Authors:  Catherine E Hughes; Robert J B Nibbs
Journal:  FEBS J       Date:  2018-04-24       Impact factor: 5.542

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.